Rational Combination Immunotherapy: Understand the Biology
نویسندگان
چکیده
منابع مشابه
A Network Biology Approach to Understand Combination of Drugs
Drug combination is becoming a popular strategy for combating complex traits, where combination of drugs improves therapy significantly over single agents. However, it is a challenging task to identify the optimal and effective combinations of drugs due to explosion of huge number of possible combinations among drugs. Therefore, it is necessary to understand the mechanisms underlying drug combi...
متن کاملCombination Immunotherapy for Melanoma.
Advances in precisionmedicine and immunology have led tomajor paradigmshifts in thegeneral approach to treatingpatientswith metastatic cancer. This is perhaps best exemplified by malignant melanoma, an aggressive tumor characterized by alterations in definedcell signalingpathwaysandsusceptibility to recognitionby the immunesystem.Over thepast4years, therehavebeen7newdrugs approved by the US Foo...
متن کاملCombination immunotherapy approaches.
Combination immunotherapy approaches involving radiation, chemotherapy, androgen manipulation and T-cell modulation have been studied extensively in animal models, setting the stage for clinical trials. Radiation therapy, in particular, is an interesting modality in this regard, leading to synergistic efficacy when used in combination with immunotherapies in several models. Chemotherapy, the fo...
متن کاملBiology and Rational Choice
These are exciting times for those interested in the connection of biology to behavior. Consider the following findings that were reported in the first half of 2005 alone. Sexual foreplay for fruit flies is fairly predictable. A male first approaches a waiting female, bumps or taps her with his leg, rubs his wings in such a way as to make music, and then begins to lick her. The remarkable recen...
متن کاملCombination immunotherapy: a road map
Cancer immunotherapy and in particular monoclonal antibodies blocking the inhibitory programed cell death 1 pathway (PD-1/PD-L1) have made a significant impact on the treatment of cancer patients in recent years. However, despite the remarkable clinical efficacy of these agents in a number of malignancies, it has become clear that they are not sufficiently active for many patients. Initial evid...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Immunology Research
سال: 2017
ISSN: 2326-6066,2326-6074
DOI: 10.1158/2326-6066.cir-17-0128